HOXA11 and neoplasm: Thus, mice harboring HSC3 tumors (that express high levels of HOXA11-AS) benefited substantially more from HOXA11-AS knockdown with respect to both tumor growth and metastasis than those with HSC4 tumors, which exhibit low HOXA11-AS expression.